Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shousha

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
Endocrine-Related Cancer|September 7, 2006
Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progressionN Sarwar, J-S Kim, J Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 1997
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancersS Fredersdorf, J Burns, A M Milne, et al.
British Journal of Cancer|January 1, 1997
Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significanceA J Desai, Y A Luqmani, J E Walters, et al.
Oncogene|September 1, 2009
The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancerN C Wortham, E Ahamed, S M Nicol, et al.
Gene Therapy|January 14, 2005
Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-alpha and the transcriptional repressor PLZFL Buluwela, J Pike, D Mazhar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2012
An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)R C Coombes, T Tat, M L Miller, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Endocrine-Related Cancer|September 7, 2006
Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progressionN Sarwar, J-S Kim, J Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 1997
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancersS Fredersdorf, J Burns, A M Milne, et al.
British Journal of Cancer|January 1, 1997
Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significanceA J Desai, Y A Luqmani, J E Walters, et al.
Oncogene|September 1, 2009
The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancerN C Wortham, E Ahamed, S M Nicol, et al.
Gene Therapy|January 14, 2005
Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-alpha and the transcriptional repressor PLZFL Buluwela, J Pike, D Mazhar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2012
An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)R C Coombes, T Tat, M L Miller, et al.
Pageof 14